tradingkey.logo

BRIEF-Pfizer Reports Strong 2024 Results And Reaffirms 2025 Guidance

ReutersFeb 4, 2025 12:20 PM

- Pfizer Inc PFE.N:

  • PFIZER REPORTS STRONG FULL-YEAR 2024 RESULTS AND REAFFIRMS 2025 GUIDANCE

  • PFIZER: ON TRACK TO DELIVER OVERALL NET COST SAVINGS OF APPROXIMATELY $4.5 BILLION BY END OF 2025

  • PFIZER: REMAIN CONFIDENT IN OUR ABILITY TO RETURN TO PRE-PANDEMIC OPERATING MARGINS IN COMING YEARS

  • PFIZER: FOURTH-QUARTER 2024 COMIRNATY REVENUE OF $3.4 BILLION

  • PFIZER: FOURTH-QUARTER 2024 PAXLOVID REVENUE OF $727 MILLION

  • FY2025 EARNINGS PER SHARE VIEW $2.93 -- LSEG IBES DATA

  • FY2025 REVENUE VIEW $63.01 BILLION -- LSEG IBES DATA

  • PFIZER -TOTAL NON-CASH INTANGIBLE ASSET IMPAIRMENT CHARGES OF $2.9 BILLION TAKEN IN Q4 2024 DUE TO CHANGES IN DEVELOPMENT PLANS

Source text: ID:nBw3tRr7Da

Further company coverage: PFE.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI